One Indian drug maker tell one BBC undercover team say im addictive cocktail drug dey “very harmful” but “dis na business”.

An Indian drug maker tells a BBC undercover team its addictive cocktail drug is “very harmful” but “this is business”.

The Friday morning market activity shows West Pharmaceutical Servs shares up by 2.21%, trading at $208.15. This implies a total value of $0 for Winters's 0 shares.

A significant insider transaction involving the exercise of company stock options was reported on February 21, by Eric Green, President at West Pharmaceutical Servs WST +2.14% Get Free Report , as per ...

A Mumbai-based pharmaceutical company, Aveo Pharmaceuticals, is reportedly manufacturing and illegally exporting unlicensed, ...

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & ...

CIBC Asset Management Inc raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,058 ...

Cipla – The company earned 30% of its revenue from North America, ranking among the top 15 U.S. prescription drug providers with a focus on respiratory and oncology generics. Biocon – The U.S. was its ...

An Indian pharmaceutical company is manufacturing unlicensed, addictive opioids and exporting them illegally to Nigeria and other countries in West Africa, consequently driving a major public health ...

The portfolio generated strong absolute returns in Q4 and 2024, and it outperformed the MSCI AC World Small Mid Index over ...

America's opioid crisis is showing signs of subsiding, a new report from the U.S. Centers for Disease Control and Prevention ...